pharm res elouahabi a and ruysschaert jm formation and intracellular trafficking of lipoplexes and polyplexes mol ther rodriguez eg nonviral dna vectors for immunization and therapy design and methods for their obtention mol med griesenbach u, geddes dm and alton ew advances in cystic fibrosis gene therapy curr opin pulm med barron lg, uyechi ls and szoka fc, jr cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes gene ther li s, tan y, viroonchatapan e, carisoprodol drug test pitt br and huang l targeted gene delivery carisoprodol drug test to pulmonary endothelium by antipecam antibody am j physiol carisoprodol drug test lung cell mol physiol l balyasnikova iv, yeomans dc, mcdonald �� and danilov sm antibody mediated lung endothelium targeting in vivo model on primates gene ther balyasnikova iv, metzger r, visintine dj, dimasius v, sun zl, berestetskaya yv, mcdonald td, curiel dt, minshall rd and danilov sm selective rat lung endothelial targeting with a new set of carisoprodol drug test monoclonal antibodies to angiotensin iconverting enzyme pulm pharmacol ther gopalan b, ito i, branch cd, stephens c, roth ja and ramesh r nanoparticle based systemic gene therapy for lung cancer molecular mechanisms and strategies to suppress nanoparticlemediated inflammatory response technol cancer carisoprodol drug test res treat li s, wu sp, whitmore m, carisoprodol drug test loeffert ej, wang l, watkins sc, pitt br and huang l effect of immune response on carisoprodol drug test gene transfer to the lung via systemic administration carisoprodol drug test of cationic lipidic vectors am j physiol l kozower bd, christofidousolomidou m, sweitzer td, muro s, buerk dg, solomides cc, albelda sm, patterson ga and muzykantov vr immunotargeting of cata lase to the carisoprodol drug test pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury nat biotechnol christofidousolomidou m, scherpereel a, wiewrodt r, ng k, sweitzer t, arguiri e, shuvaev v, solomides cc, albelda sm and muzykantov vr pecamdirected delivery of catalase to endothelium protects against pulmonary vascular oxidative stress am } physiol ll dziubla td, karim a and muzykantov vr polymer nanocarriers protecting active enzyme cargo against proteolysis} carisoprodol drug test control rel abraham sa, waterhouse dn, mayer ld, carisoprodol drug test cullis pr, madden td and bally mb the liposomal formulation of doxorubicin meth enzymol stone wl and smith m therapeutic uses of antioxidant liposomes mol biotechnol spina d phosphodiesterase inhibitors in the treatment carisoprodol drug test of inflammatory lung disease drugs peer d and margalit r tumortargeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models neoplasia lu b, zhang jq and yang h lungtargeting microspheres of carboplatin int } pharm mainardes rm and silva lp drug carisoprodol drug test delivery systems past, present, and future cwrr drug targ panyam j and labhasetwar v biodegradable nanoparticles for carisoprodol drug test drug and gene delivery to cells and tissue carisoprodol drug test adv drug del rev ulrich as biophysical aspects of using liposomes as delivery vehicles biosci rep carisoprodol drug test hans ml and lowman am biodegradable nanoparticles for carisoprodol drug test drug delivery and targeting current opin solid state mater sci discher de and eisenberg a polymer vesicles science sakuma s, suzuki n, sudo r, hiwatari carisoprodol drug test k, kishida a and akashi m optimized chemical structure of nanoparticles as carriers for oral delivery carisoprodol drug test of salmon calcitonin int j pharm constancis a, meyrueix r, bryson n, huille s, grosselin jm, gulikkrzywicki t and soula g macromolecular colloids of diblock polyamino acids that bind insulin j coll interf carisoprodol drug test sci lvov y and caruso f biocolloids with carisoprodol drug test ordered urease multilayer shells as enzymatic reactors anal carisoprodol drug test chem muro s, wiewrodt r, thomas a, koniaris carisoprodol drug test l, albelda sm, muzykantov vr and koval m a novel endocytic pathway induced by clustering endothelial icam or pecam j cell sci michaelis m, matousek j, vogel ju, slavik t, langer k, cinatl j, kreuter j and schwabe d bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro anticancer drugs bousquet y, swart pj, schmittcolin n, velgeroussel f, kuipers me, meijer dk, bru n, hoebeke j and breton p molecular mechanisms of the carisoprodol drug test adsorption of a model protein human serum albumin carisoprodol drug test on polymethylidene malonate nanoparticles pharm res muro s, muzykantov vr and murciano jc characterization of endothelial internalization and targeting of fluoxetine and lipozene antibodyenzyme conjugates in cell cultures carisoprodol drug test and in laboratory animals meth mol biol ceh b, winterhalter m, frederik pm, vallner jj and lasic dd stealth liposomes from theory to product carisoprodol drug test adv drug del rev discher bm, won yy, carisoprodol drug test ege ds, lee ccm, bates fs, discher de and hammer da polymersomes tough vesicles made from diblock copolymers science huang g, gao j, hu z, carisoprodol drug test st john jv, ponder �� and mora d controlled drug release from hydrogel nanoparticle networks ] carisoprodol drug test control rel peppas na, wood km and blanchette jo hydrogels for oral delivery of therapeutic proteins exp opin biol ther onishi h and machida y antitumor properties of irinotecancontaining nanoparticles prepared using polydllactic carisoprodol drug test acid and polyethylene glycolblock polypropylene glycolblockpolyethylene glycol biol pharm bull klibanov am improving enzymes by using carisoprodol drug test them in organic solvents nature klibanov am why are enzymes less active in organic solvents than in water?